Picture of Tenax Therapeutics logo

TENX — Tenax Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapSucker Stock

Brief: Tenax Therapeutics Q4 Net Income USD -15.54 Million

Mar 10 (Reuters) - Tenax Therapeutics Q4 operating expenses USD 16.449 million.

Q4 operating income USD -16.449 million

Recent news on Tenax Therapeutics

See all news